Martin Møller co-leads our work on R&D with pharmaceuticals and medical products companies in Europe, the Middle East, and Asia. He has extensive experience across R&D, operations, and marketing.
Recent project highlights include the creation of global launch plans that addressed supply, regulatory, and commercial issues for a primary-care blockbuster; support to a global R&D strategy and transformation program for a major pharma company; identification of strategic and operational opportunities in a small-molecule-focused R&D organization; development of a research strategy to help a client enter selected new disease areas; and the design of a new approach to cross-functional management of R&D projects.
“Outlook for the next 5 years in drug innovation,” Nature Reviews Drug Discovery, June 2012
“Escaping the sword of Damocles: Toward a new future for pharmaceutical R&D,” McKinsey, 2012 (Request a hard copy, full PDF, or iPad version of the 2012 R&D compendium)
|University of Copenhagen
||MA in comparative literature